title: Is phosphatemia the best tool to monitor renal tenofovir toxicity?
authors: Marie
authors: M
authors: Essig
authors: Xavier
authors: X
authors: Duval
authors: Firas Al
authors: FA
authors: Kaied
authors: Laura
authors: L
authors: Iordache
authors: Anne
authors: A
authors: Gervais
authors: Pascale
authors: P
authors: Longuet
authors: Francoise
authors: F
authors: Blanchet
authors: Gilles
authors: G
authors: Peytavin
authors: Catherine
authors: C
authors: Leport
mesh_terms: D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D003404:Creatinine / Q000097:blood; D005919:Glomerular Filtration Rate / Q000187:drug effects; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced* / Q000378:metabolism / Q000503:physiopathology; D007684:Kidney Tubules / Q000378:metabolism / Q000503:physiopathology; D063065:Organophosphonates / Q000009:adverse effects* / Q000627:therapeutic use; D010710:Phosphates / Q000097:blood* / Q000378:metabolism; D000068698:Tenofovir
chemical_list: D015415:Biomarkers; D063065:Organophosphonates; D010710:Phosphates; D000068698:Tenofovir; D003404:Creatinine; D000225:Adenine